TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This is a Phase II, non-randomized, open-label study to evaluate temozolomide in combination with olaparib in patients with MGMT promoter hypermethylated advanced colorectal cancer.
创建时间：
2020-06-15
